Mankind Pharma Ltd MANKIND
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ₹2,347.60
- Day Range
- ₹2,268.70–2,354.40
- 52-Week Range
- ₹1,909.70–2,642.00
- Bid/Ask
- ₹2,346.70 / ₹2,275.50
- Shares Outstanding
- 413.05M
- Market Cap
- ₹939.88B
- Volume/Avg
- 889,731 / 456,291
Key Statistics
- Price/Earnings (Normalized)
- 46.51
- Price/Sales
- 6.55
- Dividend Yield (Trailing)
- 0.00%
- Dividend Yield (Forward)
- 0.00%
- Dividend Payment Schedule
- —
- Total Yield
- —
Company Profile
Mankind Pharma Ltd is principally engaged in the manufacturing and trading of pharmaceuticals and health care products. The company develops, manufactures and markets pharmaceutical formulations across a wide spectrum of acute and chronic therapeutic areas, and consumer healthcare segment, which provides international quality products. It has one reportable segment Pharmaceuticals. It has presence in India, and Outside India. The company generates majority of revenue from India.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Large Growth
- Total Number of Employees
- 20,428
- Website
- https://www.mankindpharma.com
Valuation
|
Metric
|
MANKIND
|
|---|---|
Price/Earnings (Normalized) | 46.51 |
Price/Book Value | 5.93 |
Price/Sales | 6.55 |
Price/Cash Flow | 41.10 |
Price/Earnings
MANKIND
Financial Strength
|
Metric
|
MANKIND
|
|---|---|
Quick Ratio | 0.61 |
Current Ratio | 1.07 |
Interest Coverage | 5.43 |
Quick Ratio
MANKIND
Profitability
|
Metric
|
MANKIND
|
|---|---|
Return on Assets (Normalized) | — |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
MANKIND
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Merck KGaA ADR
MKKGY
| LOCK|PV%bPLM | LOCK|k!r> | $70B | |||
| Teva Pharmaceutical Industries Ltd
TEVA
| LOCK|P%<l!f& | LOCK|$%fg | $48B | |||
| Haleon PLC ADR
HLN
| LOCK|skVCnh | LOCK|H@T | $44B | |||
| Zoetis Inc Class A
ZTS
| LOCK|$>@wk#n | LOCK|!b# | $33B | |||
| Viatris Inc
VTRS
| LOCK|r^Kzjk | LOCK|Gq | $21B | |||
| Elanco Animal Health Inc
ELAN
| LOCK|bb | LOCK|!X | $12B | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| LOCK|mn!kl# | LOCK|n<? | $11B | |||
| Hims & Hers Health Inc Ordinary Shares - Class A
HIMS
| LOCK|gvblVJ | LOCK|SjT | $7B | |||
| Prestige Consumer Healthcare Inc
PBH
| LOCK|TpdxC$ | LOCK|!hs# | $2B | |||
| Perrigo Co PLC
PRGO
| LOCK|D#Nbs% | LOCK|Mz | $2B |
United States